These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 882828)

  • 1. Lithogenic index of bile after jejunoileal bypass operation for obesity.
    Sŏrensen TI; Bruusgaard A
    Scand J Gastroenterol; 1977; 12(4):449-51. PubMed ID: 882828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile acid metabolism after jejunoileal bypass operation for obesity.
    Bruusgaard A; Sörensen TI; Justesen T; Krag E
    Scand J Gastroenterol; 1976; 11(8):833-8. PubMed ID: 1006159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fat digestion after jejunoileal bypass operation for obesity.
    Sörensen TI; Krag E
    Scand J Gastroenterol; 1976; 11(5):491-5. PubMed ID: 959763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol saturation of bile after jejunoileal bypass increases more with a 1:3 than with a 3:1 jejunoileal ratio.
    Sørensen TI; Bruusgaard A; Andersen AN; Pedersen LR; Andersen B
    Scand J Gastroenterol; 1981; 16(7):945-50. PubMed ID: 7323720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of gallstone formation after jejunoileal bypass increases more with a 1:3 than with a 3:1 jejunoileal ratio.
    Sørensen TI; Ingemann Jensen L; Klein HC; Andersen B; Petersen O; Laursen K; Danø P; Nielsen OV
    Scand J Gastroenterol; 1980; 15(8):979-84. PubMed ID: 7233072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fasting and meal-stimulated plasma levels of neurotensin in obese patients after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio.
    Pedersen JH; Sørensen TI; Andersen B; Stadil F
    Scand J Gastroenterol; 1987 Jan; 22(1):69-74. PubMed ID: 3563413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma enteroglucagon after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio.
    Holst JJ; Sørensen TI; Andersen AN; Stadil F; Andersen B; Lauritsen KB; Klein HC
    Scand J Gastroenterol; 1979; 14(2):205-7. PubMed ID: 432544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile acid malabsorption after jejunoileal bypass is less compensated for with a 1:3 than with a 3:1 jejunoileal ratio.
    Sørensen TI; Bruusgaard A; Andersen B
    Scand J Gastroenterol; 1982 Jun; 17(4):473-80. PubMed ID: 7134874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of jejunoileal bypass on bile composition and the formation of billiary calculi.
    Wise L; Stein T
    Ann Surg; 1978 Jan; 187(1):57-62. PubMed ID: 619800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications of jejunoileal bypass related to the excluded segment.
    Branch CD; Ebenstein RS; Borgia JF; Horvath SM; Preston FW
    Surg Gynecol Obstet; 1980 Mar; 150(3):353-6. PubMed ID: 7355359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased lithogenicity of the bile after jejunoileal bypass in the rat.
    Kulneff-Herlin AE; Herlin PM; Gimmon Z; Kelley RE; Simko V; Fischer JE; Joffe SN
    Digestion; 1983; 27(1):16-20. PubMed ID: 6884584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels and clearance of bile acids are unaffected by jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio.
    Sørensen TI; Bruusgaard A; Nyboe Andersen A; Andersen B
    Scand J Gastroenterol; 1981; 16(6):705-11. PubMed ID: 7323704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jejunum and bile acid synthesis. Comparison of effects of jejunoileal bypass with 3:1 and 1:3 jejunoileal ratio.
    Sørensen TI
    Scand J Gastroenterol; 1982 Aug; 17(5):577-86. PubMed ID: 6758104
    [No Abstract]   [Full Text] [Related]  

  • 14. A prospective comparison of gastric and jejunoileal bypass procedures for morbid obesity.
    Griffen WO; Young VL; Stevenson CC
    Ann Surg; 1977 Oct; 186(4):500-9. PubMed ID: 907395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevention of bypass enteritis after jejunoileal bypass for morbid obesity.
    Hubbard TB
    Ann Surg; 1978 May; 187(5):502-9. PubMed ID: 646489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut and pancreatic hormones after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio.
    Sørensen TI; Lauritsen KB; Holst JJ; Stadil F; Andersen B
    Digestion; 1983; 26(3):137-45. PubMed ID: 6343164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Faecal steroids after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio.
    Sørensen TI; Hylander E; Miettinen TA
    Scand J Gastroenterol; 1985 Mar; 20(2):205-8. PubMed ID: 3992178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ileostomy of the distal end of the bypassed intestine in a patient with jejunoileal bypass for obesity.
    Preston FW; Svoboda AC; Horvath SM
    Am J Surg; 1978 May; 135(5):710-3. PubMed ID: 646046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with jejunoileal bypass for obesity.
    Benfield JR; Greenway FL; Bray GA; Barry RE; Lechago J; Mena I; Schedewie H
    Surg Gynecol Obstet; 1976 Sep; 143(3):401-10. PubMed ID: 1085495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma cholecystokinin in obese patients before and after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio--no role in the increased risk of gallstone formation.
    Sørensen TI; Toftdahl DB; Højgaard L; Cantor P; Klein HC; Andersen B
    Dan Med Bull; 1994 Sep; 41(4):469-72. PubMed ID: 7813254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.